Roche gets EC approval for Lunsumio to treat follicular lymphoma
The EC approval is based on positive results from the Phase ½ GO29781 study, which assessed the safety,…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
09 Jun 22
The EC approval is based on positive results from the Phase ½ GO29781 study, which assessed the safety,…
08 Jun 22
The FDA approval is based on data from a Phase 3 trial which evaluated the efficacy and safety…
07 Jun 22
Given as two doses, the vaccine can also be administered as a second shot in individuals who previously…
01 Jun 22
The US FDA approval is based on interim data from RAINBOWFISH trial, in which pre-symptomatic babies treated with…
30 May 22
The current FDA approval of Kymriah is based on data from the Phase 2 ELARA trial in which…
27 May 22
The EC conditional marketing authorisation was based on the CARTITUDE-1 study, in which 98% of patients responded to…
27 May 22
The potential combination therapy comprises diacylglycerol O-acyltransferase 2 (DGAT2) inhibitor ervogastat and an acetyl-CoA carboxylase (ACC) inhibitor clesacostat
26 May 22
Polivy in combination with MabThera (rituximab), cyclophosphamide, doxorubicin, and prednisone (R-CHP) is indicated for adult patients with previously…
25 May 22
The company’s BLA is supported by results from the HOPE-B clinical trial that evaluated the safety and efficacy…
25 May 22
The recall has led to a shortage of baby milk formula products in the US, and the consent…